ENTGMEDIUM SIGNALFINANCIAL10-K

ENTG shows mixed financial performance with strong cash flow growth offset by declining profitability metrics and significantly reduced interest expenses.

The company demonstrates operational resilience with 10% operating cash flow growth despite 15% operating income decline, suggesting effective working capital management. The 31% reduction in interest expense indicates successful debt reduction or refinancing, while the stronger balance sheet (+32% stockholders' equity) provides financial flexibility for future investments.

Comparing 2026-02-11 vs 2025-02-12View on EDGAR →
FINANCIAL ANALYSIS

ENTG delivered mixed results with operating cash flow growing 10% to $695M while operating income declined 15% and net income fell 20%, indicating margin pressure despite solid cash generation. The company significantly strengthened its balance sheet with stockholders' equity rising 32% and interest expense dropping 31%, reflecting successful debt management and improved financial positioning. Overall, the financial picture suggests operational challenges in the near term but enhanced financial stability and cash generation capability for long-term growth investments.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+32.3%
$459.6M$608.2M

Equity base grew 32.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Interest Expense
P&L
-31.1%
$312.4M$215.2M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Net Income
P&L
-19.5%
$292.8M$235.6M

Net income declined 19.5% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-14.6%
$533.9M$455.9M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Operating Cash Flow
Cash Flow
+10.1%
$631.7M$695.4M

Operating cash flow grew 10.1% — strong conversion of earnings to cash, healthy business fundamentals.

LANGUAGE CHANGES
NEW — 2026-02-11
PRIOR — 2025-02-12
ADDED
As of February 6, 2026, 152.0 million shares of the registrant s Common Stock were outstanding.
We leverage our unique breadth of capabilities to provide customers with innovative, science-based solutions to their toughest technology challenges, helping improve productivity and product performance in the most advanced manufacturing environments.
Semiconductors, or integrated circuits, are key components in electronic devices that continue to transform how we live, communicate and work.
Many products and emerging applications including artificial intelligence ( AI ), high-performance and cloud computing, smartphones, wearable technology, electric and autonomous vehicles, the Internet of Things, gaming, virtual/augmented reality, and smart healthcare are expected to drive long-term secular demand for semiconductor and require faster, more powerful, more compact and more energy efficient semiconductors.
Industry forecasts project semiconductor sales reaching approximately $1.6 trillion by 2030, which we believe will create significant opportunities for our products.
As semiconductors move to smaller geometries and new device architectures, they require innovative materials and stringent purity standards throughout manufacturing.
Entegris offers the industry s most comprehensive electronic materials portfolio, with core capabilities in materials science and materials purity, and complementary solutions that accelerate time to yield.
We expect these trends to create significant opportunities for our products, expand our served addressable market and increase Entegris content per wafer, positioning us to outperform our markets over the long term.
Our business is organized and operated in two operating segments.
Our complementary capabilities enable co-optimized, integrated solutions that improve device performance, lower cost of ownership and accelerate time to market.
REMOVED
As of February 5, 2025, 151,126,743 shares of the registrant s Common Stock were outstanding.
We leverage our unique breadth of capabilities to help our customers improve their productivity, product performance and technology in the most advanced manufacturing environments.
Semiconductors, or integrated circuits, are key components in electronic devices that continue to change the way we live, communicate and work.
Products and emerging applications such as artificial intelligence, high-performance and cloud computing, smartphones, wearable technology, self-driving vehicles, the Internet of Things, gaming and virtual reality, and smart healthcare will require faster, more powerful, more compact and more energy efficient semiconductors.
We believe these trends, combined with existing applications, will drive long-term secular growth for semiconductors, with semiconductor sales reaching approximately $1 trillion by 2030, creating significant opportunities for our products.
To meet the demanding requirements of advanced products and applications, semiconductors have rapidly become increasingly complex, moving to smaller geometries and adopting new device architectures.
These advancements are enabled by new and innovative materials and ensuring the purity of the materials and the cleanliness of wafers throughout the manufacturing process.
We believe Entegris offers the industry s most comprehensive electronic materials portfolio, with core capabilities in materials science and materials purity, and complementary solutions that enable faster time to yield.
We expect these trends to translate into a higher served addressable market for our products and to expand Entegris content per semiconductor wafer, which we believe will allow us to achieve growth that outperforms our markets.
In the fourth quarter of 2024, the Company announced an internal reorganization, combining two complementary divisions into one and realigning its customer facing organization.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →